Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,290,807 papers from all fields of science
Search
Sign In
Create Free Account
fruquintinib
An orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
HMPL-013
NCIt Antineoplastic Agent Terminology
Receptor Tyrosine Kinase Inhibition
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Painkilling anti-NGF antibodies stage phase III comeback
Asher Mullard
Nature reviews. Drug discovery
2018
Corpus ID: 52892876
2018
2018
Fruquintinib Extends PFS in Pretreated Advanced NSCLC
D. Levitan
2018
Corpus ID: 181481443
The kinase inhibitor fruquintinib offered improved outcomes vs placebo as a third- and fourth-line treatment in advanced non…
Expand
2018
2018
Chi-Med scores key approval for 'discovered in China' cancer drug
Asher Mullard
Nature reviews. Drug discovery
2018
Corpus ID: 52890416
prove their ability to discover and develop follow-on drug contenders with best-in-class potential. First-generation VEGFR…
Expand
2013
2013
Hutchison MediPharma Partners with Eli Lilly to Advance Development of Fruquintinib in China
Heather Cartwright
2013
Corpus ID: 73988792
Hutchison MediPharma (HMP), the R&D division of the Chinese pharmaceutical and healthcare group Hutchison Chi-Med, has partnered…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE